Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

The prevalence rate of VTE was 2% among a large population of SCD  patients  in Nigeria. 

Low Prevelance of VTE Observed Among Cohort with Sickle Cell Disease

Data show the presence of five and six risk factors increased the risk of VTE exponentially to 10.9% and 25%, respectively

Multiple Risk Factors Increase Risk for VTE After Surgery for IBD 

In a population aged 70 years and older, a remote history of VT was associated with an increased risk of VT independent of other factors. 

Remote History of Venous Thrombosis Associated with Risk at Older Age 

Apixaban prescription beyond 90 days showed no difference in hospitalization risk for major bleeding. 




Extended Apixaban Treatment Associated With Lower VTE Hospitalization Rate  

Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.

Oxford–AstraZeneca COVID-19 Vaccine Associated with Small Excess Risk of Deep Venous Thrombosis

A recent study showed anticoagulant therapy for 6 weeks compared to 3 months met noninferiority criteria, based on a combination of recurrent VTE risk and bleeding risk.


Reduced Anticoagulant Duration for VTE Noninferior in Patients Younger Than 21 Years 

Recurrent VTE shows a higher rate than expected for patients with subsegmental pulmonary embolism without proximal deep vein thrombosis managed without anticoagulation.




Subsegmental Pulmonary Embolism Linked to Increased Rate of VTE

Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge. 

Postdischarge Anticoagulation Use Reduces VTE Risk After COVID-19 Hospitalization 

Incidence rates of post-Ad26.COV2.S vaccination cerebral venous sinus thrombosis was 8.65 per 100,000 person-years. 

High Incidence of CVST Observed 15 Days After COVID-19 Vaccination 

Analysis data show 3 times more risk of intensive care unit care in patients with venous thromboembolism compared to non-VTE patients (RR: 2.78). 

High Incidence of VTE Observed in ICU Hospitalizations for COVID-19

The HCPLive venous thromboembolism page is a resource for medical news and expert insights on VTE. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.

Venous Thromboembolism